JPRN-UMIN000002112已完成未知
Healing Effect of Gastric mucosal Lesion of patient with Osteoarthritis or Rheumatism by Cox2-Inhibitor and Anti ulcer agent(Rebamipide) combination therapy. - GLORIA
Department of Orthopaedic Surgery, Mie University Hospital Department of Gastroenterology and Hepatology, Mie University Hospital0 个研究点目标入组 300 人开始时间: 2009年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •History of gastrointestinal surgery Presence of gastroesophageal reflex disease (GERD) Presence of malignancy Presence of gastrointestinal bleeding or gastrointestinal ulcer Presence of aspirin-induced asthma Pcesence of severe cardiac disorder, renal disorder or liver disorder Impossibility of endoscopic examination Presence of allergy of celecoxib or rebamipide History of percutaneous coronary revascularization Pregnancy and lactation Impossibility of discontinuation of proton pump inhibitor or histamine-2 receptor antagonist Administration of NSAID that excludes aspirin Patient who doctor judged improper
研究者
相似试验
已完成
不适用
Examination on mucosal healing in mild to moderate active ulcerative colitis with mesalazine: a multicentre prospective open studylcerative colitisJPRN-UMIN000010668Dokkyo Medical University80
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-000492-33-LTALTANA Pharma AG800
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeksEUCTR2004-000492-33-LVALTANA Pharma AG800
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade A-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeksGastroesophageal reflux esophagitisMedDRA version: 5.0Level: lltClassification code 10038263EUCTR2004-000493-32-ATALTANA Pharma AG1,980
进行中（未招募）
不适用
Healing of patients suffering from gastroesophageal reflux esophagitisgrade C-D according to Los Angeles classification after treatment with pantoprazole-magnesium dihydrate 80 mg o.d. in comparison topantoprazole-sodium sesquihydrate 40 mg o.d. over 4 or 8 weeks - Magnum IIEUCTR2004-000492-33-HUALTANA Pharma AG800